Table 2 Patients and pathological characteristics
Variable | N (%) |
|---|---|
Follow-up (months) | 48 (1–249) |
Age (mean) | 66 (39 – 87) |
Smoking | |
No | 20 (32.7) |
Yes | 41 (67.2) |
Hydronephrosis | |
No | 36 (59.0) |
Yes | 25 (41.0) |
ASA classification | |
1 | 4 (6.5) |
2 | 36 (59.0) |
3 | 21 (34.5) |
Histology | |
Urothelial carcinoma | 58 (95,1) |
CIS | 2 (3.1) |
Without Tumor | 1(1,6) |
pT stage | |
T0 | 3 (4,9) |
Tis | 2 (3.2) |
Ta | 6 (9.8) |
T1 | 9 (14.8) |
T2 | 16 (26.2) |
T3a | 8 (13.1) |
T3b | 7 (11.5) |
T4 | 12 (19.7) |
Histological grade | |
Low | 18 (31.0) |
High | 40 (69.0) |
Pathologic grade | |
0 | 3 (4,9) |
1 | 6 (9,8) |
2 | 12 (19,7) |
3 | 26 (42,6) |
4 | 14 (26) |
Vascular invasiona | |
No | 44 (84.6) |
Yes | 8 (15.4) |
Lymphatic invasiona | |
No | 33 (63.4) |
Yes | 19 (36.5) |
Perineural invasiona | |
No | 26 (76.4) |
Yes | 8 (23.6) |
Disease progression | |
No | 42 (68.9) |
Yes | 19 (31.1) |
Cancer Survival | |
12 m | (82,4) |
24 m | (68) |
36 m | (61,8) |
48 m | (50,9) |
60 m | (45,2) |